NCT06415214View on ClinicalTrials.gov

Efficacy and Safety of HRS-7535 Tablets in Adults With Type 2 Diabetic Kidney Disease

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

186

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions

Type 2 Diabetic Kidney Disease

Interventions

DRUG

Placebo

Placebo

DRUG

HRS-7535

HRS-7535

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY